FDA Homepage
-
-
FDA takes steps under new Drug Competition Action Plan
- Lists off-patent drugs without approved generics, implements new policy to expedite application review.
- FDA takes steps under new Drug Competition Action Plan
-
-
-
Tattoo Removal: Options and Results
- How hard is it to remove a tattoo? What processes are used? Is it painful?
- Tattoo Removal: Options and Results
-
-
-
FDA seeks input on barriers to generic drug competition
- Agency announces public meeting to discuss areas where competition may be stalled.
- FDA seeks input on barriers to generic drug competition
-
News & Events
- June 27, 2017 - FDA Tackles Drug Competition to Improve Patient Access
- June 26, 2017 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs
- June 22, 2017 - FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
Newsroom
Recent Consumer Updates
Browse by Audience
-
For Consumers
Updates and information for staying safe and healthy -
For Patients
Learn about other treatments, drug/device approvals, public meetings and more -
For Health Professionals
Medical product safety information, adverse event/problem reporting and more -
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative and more -
For Industry
Guidance, registration and listing, pay user fees, import programs and more
FDA Voice Blog
Page Last Updated: 06/28/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English